about
TRPC6 channel as an emerging determinant of the podocyte injury susceptibility in kidney diseasesAssociation between Blood Dioxin Level and Chronic Kidney Disease in an Endemic Area of ExposureMangiferin attenuates diabetic nephropathy by inhibiting oxidative stress mediated signaling cascade, TNFα related and mitochondrial dependent apoptotic pathways in streptozotocin-induced diabetic ratsDiabetic nephropathy and antioxidants.Geographical genomics of human leukocyte gene expression variation in southern MoroccoHepatocyte nuclear factor 1 and hypertensive nephropathy.Glutathione S-transferase Mu 2-transduced mesenchymal stem cells ameliorated anti-glomerular basement membrane antibody-induced glomerulonephritis by inhibiting oxidation and inflammationIntracellular calreticulin regulates multiple steps in fibrillar collagen expression, trafficking, and processing into the extracellular matrix.Decrease of Klotho in the kidney of streptozotocin-induced diabetic ratsRandomized controlled trial of strain-specific probiotic formulation (Renadyl) in dialysis patientsTempol, a superoxide dismutase mimetic agent, ameliorates cisplatin-induced nephrotoxicity through alleviation of mitochondrial dysfunction in miceAngiotensin II-induced mitochondrial Nox4 is a major endogenous source of oxidative stress in kidney tubular cellsPredictors of autosomal dominant polycystic kidney disease progression"Silymarin", a promising pharmacological agent for treatment of diseasesThe podocyte power-plant disaster and its contribution to glomerulopathy.Loss of endogenous bone morphogenetic protein-6 aggravates renal fibrosis.Oxidative stress mediates nephropathy in type Ia glycogen storage disease.The proximal tubule in the pathophysiology of the diabetic kidney.Noninvasive in vivo imaging of diabetes-induced renal oxidative stress and response to therapy using hyperpolarized 13C dehydroascorbate magnetic resonance.High-fat diet induces an initial adaptation of mitochondrial bioenergetics in the kidney despite evident oxidative stress and mitochondrial ROS production.Aqueous Extract from Hibiscus sabdariffa Linnaeus Ameliorate Diabetic Nephropathy via Regulating Oxidative Status and Akt/Bad/14-3-3γ in an Experimental Animal ModelGhrelin protects against renal damages induced by angiotensin-II via an antioxidative stress mechanism in mice.Oxidative stress and galactose-deficient IgA1 as markers of progression in IgA nephropathy.Sodium tanshinone II A sulfonate ameliorates microcirculatory disturbance of small intestine by attenuating the production of reactie oxygen species in rats with sepsis.Salvianolic acid A as a multifunctional agent ameliorates doxorubicin-induced nephropathy in ratsIdiopathic recurrent calcium urolithiasis (IRCU): variation of fasting urinary protein is a window to pathophysiology or simple consequence of renal stones in situ? A tripartite study in male patients providing insight into oxidative metabolism as pProtective effect of Nrf2 and catalase in maternal diabetes-induced perinatal hypertension and kidney disease.Fenofibrate, a PPARα agonist, protect proximal tubular cells from albumin-bound fatty acids induced apoptosis via the activation of NF-kB.Non transferrin bound iron: nature, manifestations and analytical approaches for estimationMelatonin attenuates hypertension-induced renal injury partially through inhibiting oxidative stress in rats.Advanced oxidation protein products activate intrarenal renin-angiotensin system via a CD36-mediated, redox-dependent pathway.Epoetin beta pegol alleviates oxidative stress and exacerbation of renal damage from iron deposition, thereby delaying CKD progression in progressive glomerulonephritis ratsBeyond efficacy and safety-the need for convenient and cost-effective iron therapy in health careTargeting the transcription factor Nrf2 to ameliorate oxidative stress and inflammation in chronic kidney diseaseNuclear factor κB mediates suppression of canonical transient receptor potential 6 expression by reactive oxygen species and protein kinase C in kidney cellsDiminished antioxidant activity of high-density lipoprotein-associated proteins in chronic kidney diseaseErythropoietin ameliorates hyperglycemia in type 1-like diabetic rats.Secreted klotho and chronic kidney diseaseRenal function in diabetic disease models: the tubular system in the pathophysiology of the diabetic kidney.Iodinated contrast media can induce long-lasting oxidative stress in hemodialysis patients
P2860
Q28081895-1CF64C4A-D1A0-4932-B3B2-F69DF5D6EE55Q28389314-FDB1D591-BC7A-4511-8327-D73520B425E4Q28543063-4FF0C80D-C281-4164-AFAB-7E0BC58051A6Q30486658-D523ED17-A39E-43F1-9CDB-521DDD6ADA49Q33560717-7EB91B72-F495-4B6D-B004-9B468466C0B3Q33734218-55623895-9BDC-4D91-82ED-6E7E6BE67CECQ33746135-6388F2E3-CC18-4654-B931-9A0812BC6412Q33747983-393492DF-1805-48E8-BE41-815AE7C5A69AQ33960130-F930D287-FDC7-4A0D-88F3-C45EE23B25D4Q34043268-DC3B0EB5-5411-4F0F-B802-F00EF7138726Q34278299-98EECFF9-4D0C-47BC-ACF4-145871385277Q34341622-830F4792-6A8B-426B-BABE-9C867991EB0AQ34427678-2EB0D3CB-54D0-403B-BD4E-1076F77D512BQ34649335-97312D49-1AAF-4CEE-BC10-CCD946BCA9D9Q34699773-5550778C-94AA-4A85-96C9-F0F6DFC9E3E2Q34760586-BB8343B1-FD28-46ED-BF0D-E4E73B90CADAQ34807521-9D489B88-3E32-4E3B-9207-F176D2C1B50FQ34979592-890892C5-7D2A-40C5-9796-B36AF3591B21Q35004286-B7B501EC-F44E-4C7A-BB32-957D72BEA326Q35055477-093A7819-8231-4F3F-A910-5CE4CCF1289FQ35115019-2597F17E-D04C-4BC0-817F-EA2EEB933483Q35152716-287F5D5A-0C29-4A79-99CB-28A1C1C794D4Q35165506-C5069EAF-8D06-4BA6-B1F8-9608653110E2Q35756803-BA007265-9199-4701-989C-283CDC0C00DEQ35869192-BC2F498E-FCBF-4A61-8180-7CB2C93893C5Q35959059-537DD90B-3231-4865-8ABF-604014C22A11Q36249811-9C886F78-6E94-4454-86D1-EE37B41FD416Q36261482-4676D4D7-712A-441E-8FC6-36F5B5FBE38DQ36336362-3F76CF70-4848-4760-996C-93A14B89EFD3Q36390341-986E75D7-5FD7-4C49-A072-8E5BCB55323DQ36415711-CE159280-9C15-413A-A781-F08A853FBA21Q36597896-288C1944-17E5-471C-B39F-3DE0DAED6359Q36745330-E78E8726-DF53-4F8A-9BC2-72F985D44D38Q36788430-2F6147C1-12D4-442E-813D-F9706C42514DQ36812431-7A9E9859-45A5-48FA-AC5A-FA3D00D5C6FDQ36824691-AFD0AFE7-6F32-4972-A5A1-2F41D18C2D94Q36992357-683152BC-4572-4EB7-8F68-094167CBABCFQ37190542-C0882D03-EB0D-465A-871B-D6334F36137BQ37253944-9EA6B58D-37BA-47EA-90C7-109CA0FA4360Q37259512-8E9FE4D1-CDD5-41D9-A919-BC081439D7BE
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Oxidants in chronic kidney disease.
@ast
Oxidants in chronic kidney disease.
@en
type
label
Oxidants in chronic kidney disease.
@ast
Oxidants in chronic kidney disease.
@en
prefLabel
Oxidants in chronic kidney disease.
@ast
Oxidants in chronic kidney disease.
@en
P2093
P356
P1476
Oxidants in chronic kidney disease.
@en
P2093
Mohan Rajapurkar
Radhakrishna Baliga
Sudhir V Shah
Vivian A Fonseca
P356
10.1681/ASN.2006050500
P577
2006-12-13T00:00:00Z